We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+22.33%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$385B
AUM Growth
+$32.1B
Cap. Flow
-$35.1B
Cap. Flow %
-9.14%
Top 10 Hldgs %
30.5%
Holding
11,975
New
1,989
Increased
4,461
Reduced
4,218
Closed
1,130

Sector Composition

Rank Sector Weight
1 Technology 3.78%
2 Healthcare 3.27%
3 Industrials 2.02%
4 Financials 2.02%
5 Consumer Discretionary 1.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FRMM
10226
Forum Markets
FRMM
$80.6M
$77K ﹤0.01%
+7
New +$149K
DHF
10227
BNY Mellon High Yield Strategies Fund
DHF
$175M
$77K ﹤0.01%
+25,683
New +$73.4K
HUIZ
10228
Huize Holding Ltd
HUIZ
$12.9M
$77K ﹤0.01%
+2,213
New +$82.1K
KTCC icon
10229
CALL
Key Tronic
KTCC
$42.4M
$77K ﹤0.01%
+11,200
New +$91.6K
RKDA icon
10230
CALL
Arcadia Biosciences
RKDA
$1.31M
$77K ﹤0.01%
+761
New +$92.9K
SLE icon
10231
Super League Enterprise
SLE
$4.05M
$77K ﹤0.01%
+3
New +$59.4K
NEW
10232
PUT
DELISTED
Puxin Limited American Depositary Shares, each representing twenty Ordinary Shares
NEW
$77K ﹤0.01%
+1,330
New +$101K
GYRE icon
10233
PUT
Gyre Therapeutics
GYRE
$710M
$76K ﹤0.01%
+1,613
New +$69.8K
OGI
10234
Organigram Holdings
OGI
$172M
$76K ﹤0.01%
14,343
+8,061
+128% +$41.4K
RYAM icon
10235
PUT
Rayonier Advanced Materials
RYAM
$567M
$76K ﹤0.01%
11,700
-6,800
-37% -$36K
SMMT icon
10236
Summit Therapeutics
SMMT
$10.7B
$76K ﹤0.01%
+16,170
New +$68.5K
TMQ
10237
Trilogy Metals
TMQ
$646M
$76K ﹤0.01%
37,805
+22,560
+148% +$40K
CNR
10238
CALL
Core Natural Resources Inc
CNR
$4.77B
$76K ﹤0.01%
10,500
-900
-8% -$4.71K
CORR
10239
PUT
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
$76K ﹤0.01%
11,100
-9,400
-46% -$56.8K
PHAS
10240
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$76K ﹤0.01%
22,693
+7,166
+46% +$25.7K
ACTG icon
10241
CALL
Acacia Research
ACTG
$447M
$75K ﹤0.01%
19,000
-1,800
-9% -$6.46K
ARCO icon
10242
CALL
Arcos Dorados Holdings
ARCO
$1.67B
$75K ﹤0.01%
15,113
-15,519
-51% -$70.9K
ASUR icon
10243
PUT
Asure Software
ASUR
$245M
$75K ﹤0.01%
+10,600
New +$80.8K
ATXS
10244
CALL
DELISTED
Astria Therapeutics
ATXS
$75K ﹤0.01%
5,850
+2,300
+65% +$41K
CIG.C icon
10245
CEMIG Ordinary Shares
CIG.C
$8.1B
$75K ﹤0.01%
+39,255
New +$59.3K
CTRM icon
10246
Castor Maritime
CTRM
$22.6M
$75K ﹤0.01%
+4,080
New +$63.5K
DBVT
10247
PUT
DBV Technologies
DBVT
$879M
$75K ﹤0.01%
2,860
-710
-20% -$15.7K
FTEK icon
10248
PUT
Fuel Tech
FTEK
$45.3M
$75K ﹤0.01%
+19,300
New +$43.8K
FURY
10249
Fury Gold Mines
FURY
$117M
$75K ﹤0.01%
52,268
+20,529
+65% +$36.6K
HGLB
10250
Highland Global Allocation Fund
HGLB
$178M
$75K ﹤0.01%
+11,424
New +$68.3K

Similar funds

Ken Griffin's Q4 2020 Portfolio in Review

As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.

  • Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
  • Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
  • Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
  • Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
  • Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
  • Ken Griffin opened 1,989 new positions and closed 1,130 in Q4 2020.
  • Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.

Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.